1Miyagi T,Koshida K,Hori O,et al.Gene therapy for prostate cancer using the cytosine deaminase/uracil phosphofibosyltransferase suicide system[ J ]. J Gene Med,2003,5 ( 1 ) :30 - 37.
2Bourbeau D,Lavoie G,Nalbantoglu J ,et al. Suicide gene therapy with an adenovirus expressing the fusion gene CD:UPRT in human glioblastomas:different sensitivities correlate with p53 status[J]. J Gene Med, 2004,6:1320 - 1332.
3Porosnicu M, Mian A, Barber GN. The oncolytic effect of recombinant vesicular stornatitis virus is enhanced by expression of the fusion cytosine deaminase/uracil phosphoribosyhransferase suicide gene [ J]. Cancer Res ,2003,63:8366 - 8376.
4Andersen PS, Smith JM, Mygind B. Characterization of the upp gene encoding aracil phosphoribosytransterase of Escherichia coli k12 [ J ]. Eur J Biochem, 1992,204:51 - 56.
5Sehoensiegel F, Paschen A, Sieger S, et al. MIA( melanoma inhibitory activity) promoter mediated tissue-specific suicide gene therapy of malignant melanoma [ J ]. Cancer Gene Ther,2004,11 (6) :408 - 418.
6Tanaka-Nozaki M,Onda M,Tanaka N,et al. Variations in 5-fluorouracil concentrations of colorectal tissues as compared with dihydropyrimidine dehydrogenase(DPD)enzyme activities and DPD messenger RNA level [ J ]. Clin Cancer Res, 2001,7:2783 - 2787.
7Koyama F, Sawada H, Hirao T,et al. Combined suicide gene therapy for human colon cancer cells using adenovirus-mediated transfer of escherichia coli cytosine deaminase gene and Escherichia eoli uracil phosphorihosy ltransferase gene with 5-fluorocytosine [ J ]. Cancer C, ene Ther, 2000,7(7) :1015 - 1022.
9Adachi Y, Tamiya T, Ichikawa T, et al brain tumors using Experimental gene therapy for transfer of cytosine deaminase gene and uracil phosphoribosyitransferase gene with 5-fluorocytosine [ J ]. Hum Gene Ther,2000,11 ( 1 ) :77 - 89.
3Zhang S,Yuan S,Zhu Z,et al. Apoptosis induced by 5-flucytosine in human pancreatic cancer cells genetically modified to express cytosine deaminase. Acta Pharmacol Sin,2000,21:655-659.
4Sherr CJ. Cancer cell cycle. Science,1996,274: 1672-1677.
5Rossi DJ,Londesborough A,Korsiaari N,et al. Inability to enter S phase and defective RNA polymerase II CTD phosphorylation in mice lacking Mat1. EMBO J,2001,20:2844-2856.
6Wang J,Barsky LW,Shum CA,et al. Retinoid-induced G1 arrest and differentiation activation are associated with a switch to cyclin-dependent kinase-activating kinase hypophosphorylation of retinoic acid receptor alpha. J Biol Chem,2002,277:43369-43376.
7Sherr CJ,McCormick F. The RB and p53 pathways in cancer. Cancer Cell, 2002,2:103-112.
8Ortega S,Malumbres M,Barbacid M. Cyclin D-dependent kinases,INK4 inhibitors and cancer. Biochim Biophys Acta,2002,1602:73-87.
9Yee A,Nichols MA,Wu L,et al. Molecular cloning of CDK7-associated human MAT1, a cyclin-dependent kinase-activating kinase (CAK) assembly factor. Cancer Res,1995,55:6058-6062.
